CN111793723A - Duplex RT-PCR detection primer for duck hepatitis C virus and novel duck picornavirus - Google Patents

Duplex RT-PCR detection primer for duck hepatitis C virus and novel duck picornavirus Download PDF

Info

Publication number
CN111793723A
CN111793723A CN202010882032.4A CN202010882032A CN111793723A CN 111793723 A CN111793723 A CN 111793723A CN 202010882032 A CN202010882032 A CN 202010882032A CN 111793723 A CN111793723 A CN 111793723A
Authority
CN
China
Prior art keywords
duck
dumv
duhcv
virus
pcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010882032.4A
Other languages
Chinese (zh)
Other versions
CN111793723B (en
Inventor
陈翠腾
刘斌琼
陈珍
朱春华
蔡国漳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Animal Husbandry and Veterinary of Fujian Academy of Agricultural Sciences
Original Assignee
Institute of Animal Husbandry and Veterinary of Fujian Academy of Agricultural Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Animal Husbandry and Veterinary of Fujian Academy of Agricultural Sciences filed Critical Institute of Animal Husbandry and Veterinary of Fujian Academy of Agricultural Sciences
Priority to CN202010882032.4A priority Critical patent/CN111793723B/en
Publication of CN111793723A publication Critical patent/CN111793723A/en
Application granted granted Critical
Publication of CN111793723B publication Critical patent/CN111793723B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a dual RT-PCR detection primer for duck hepatitis C virus and novel duck picornavirus, which comprises the following steps: specific primer sequences aiming at the duck hepatitis C virus are shown as SEQ.ID.No.1 and SEQ.ID.No.2, and the size of a target fragment is 502 bp; specific primers for the novel duck picornavirus are shown as SEQ.ID.No.3 and SEQ.ID.No.4, and the size of a target fragment is 255 bp. The primer can be used for establishing a dual RT-PCR detection method for differential diagnosis of DuHCV and DuMV, the method can be used for simultaneously detecting DuHCV and DuMV infection in duck groups, the operation procedure is simplified, the repeated detection of conventional PCR is avoided, and the method has the advantages of low cost, high efficiency and the like.

Description

Duplex RT-PCR detection primer for duck hepatitis C virus and novel duck picornavirus
Technical Field
The invention belongs to the field of animal virology, and particularly relates to a dual RT-PCR (reverse transcription-polymerase chain reaction) detection primer for duck hepatitis C virus and novel duck picornavirus.
Background
The aquatic bird breeding amount of China is the first in the world and is an important component of poultry industry, however, in recent years, various new infectious diseases appear in the aquatic birds of China in succession without breaking off, and the occurrence of the new infectious diseases causes huge economic loss to the aquatic bird industry of China and becomes a key factor which seriously restricts the healthy and stable development of the aquatic bird industry of China.
According to the latest classification of the International Committee for viral classifications (International Committee on Taxonomy of viruses), 4 virus genera were set under the Flaviviridae Family (Flaviviridae Family): flaviviruses (Flavivirus), 53 virus species, some of which are zoonotic pathogens such as epidemic encephalitis b virus, dengue virus; hepacivirus type c (hepacivirus), there are 14 virus species; pegivirus genus, 11 species; pestiviruses (pestiviruses) are 11 species, and are commonly exemplified by classical swine fever virus and bovine viral diarrhea virus. Hepatitis C Virus (HCV) is a single-stranded positive-stranded RNA virus belonging to the genus hepatitis C virus of the family flaviviridae, the virion of which is spherical and has a diameter of about 40-60nm, and the nucleocapsid is icosahedral in symmetry and surrounds a lipid-containing envelope with spikes. Duck hepatitis c virus (DuHCV) is a newly discovered hepatitis c virus from a duck group suffering from egg laying abnormality, the genome of the duck hepatitis c virus has the characteristics of general hepatitis c, is single-stranded positive-strand RNA, has the length of 11422bp, encodes an Open Reading Frame (ORF) with the length of 10824bp, and encodes a polyprotein with the length of 3607 amino acids.
Viruses of the Picornaviridae Family (Picornaviridae Family) are important zoonotic pathogens that cause subclinical infections or severe illnesses ranging from mild fever to the heart, liver and central nervous system in humans and animals. Picornaviridae viruses are a class of icosahedral, symmetrical, spherical, single-stranded, positive-stranded RNA viruses of about 20-30nm diameter that are membrane-free. The viruses of the family picornaviridae include 63 virus genera, and commonly include the genus foot-and-mouth disease virus (Aphthovirus), the genus Enterovirus (Enterovirus), the genus Cardiovirus (Cardiovirus), the genus hepacivirus (Hepatovirus), and the like. The length of the gene of the virus in the family of picornaceae is generally 6.6kb-9.8kb, the genome generally only contains one large Open Reading Frame (ORF), the 3 'end is a Poly A tail, the 5' end is covalently bound with VPg protein, and the genome RNA is infectious. In recent years, with the progress of viral metagenomics, pathogens belonging to the genus Megrivirus of the family picornaceae have been discovered in the past from turkeys, chickens, pigeons, and ducks. Genomic analysis shows that the genome structural characteristics of the duck novel picornavirus (DuMV) are similar to those of turkey-derived megrivus and chicken-derived megrivus, and the polyprotein of the duck novel picornavirus contains characteristic motifs of typical picornaviridae viruses. Genetic evolutionary analysis shows that the novel duck picornavirus (DuMV) and the novel Megrivirus (Megrivirus) turkey, chicken and pigeon source picornaviruses belong to the same genetic evolutionary branch.
However, no research report of primers for carrying out a dual RT-PCR detection method on two new duck group viruses, namely duck hepatitis C virus (DuHCV) and duck novel picornavirus (DuMV), is available at present, and the establishment of the invention can fill the blank of related fields at home and abroad. The dual RT-PCR detection method established by the invention can be used for carrying out differential diagnosis on DuHCV and DuMV which are popular in duck groups, lays a foundation for developing new DuHCV and DuMV epidemiological investigation and subsequent scientific prevention and control of related diseases in duck groups, and has very important research significance.
Disclosure of Invention
The invention aims to provide a dual RT-PCR detection primer and a kit for duck hepatitis C virus and duck novel picornavirus, and establishes a dual RT-PCR detection method capable of carrying out differential diagnosis on DuHCV and DuMV prevalent in a duck group, thereby laying a foundation for developing new DuHCV and DuMV epidemiological investigation and subsequent scientific prevention and control related diseases in the duck group and having very important research significance.
The purpose of the invention is realized by the following technical scheme:
a dual RT-PCR detection primer for duck hepatitis C virus and novel duck picornavirus comprises the following primers:
specific primers for duck hepatitis C virus:
DuHCV-F:5’-GTTACTACCTATCTACGCAATT-3’;
DuHCV-R:5’-AGATGGCACTGGGATCGATGTA-3’;
the size of the target fragment is 502 bp;
specific primers aiming at the novel duck picornavirus:
DuMV-F:5’-TGTCAGCGCTATGATGGAGA-3’;
DuMV-R:5’-AATCCTTCCACCATCATCCAGT-3’;
the size of the target fragment was 255 bp.
The double RT-PCR detection method for detecting the duck hepatitis C virus and the novel duck picornavirus by using the primers has the PCR reaction system as follows: the following components were contained in a 50. mu.L system:
component name Volume (μ L)
2 × Multiple PCR Buffer PCR amplification reaction solution 25
DuHCV-F(10μmol/L) 0.4
DuHCV-R(10μmol/L) 0.4
DuMV-F(10μmol/L) 0.6
DuMV-R(10μmol/L) 0.6
PCR amplification enzyme 0.25
cDNA template 1.0
Sterilizing deionized water 21.75
The PCR reaction conditions are as follows: carrying out pre-denaturation at 94 ℃ for 120s, then carrying out circulation, carrying out denaturation at 94 ℃ for 30s, annealing at 57 ℃ for 45s, and extending at 72 ℃ for 45s, carrying out final extension at 72 ℃ for 10min after 35 cycles are finished, and carrying out identification according to conventional agarose gel electrophoresis after the reaction is finished.
If the detection sample only contains DuHCV, only one amplified target fragment is provided, and the size is 502 bp; if the detection sample only contains DuMV, only one amplified target fragment is provided, and the size of the amplified target fragment is 255 bp; if the detection sample contains DuHCV and DuMV, two amplified target fragments are provided, namely 502bp and 255bp respectively; if DuHCV and DuMV are not present in the test sample, no amplified band is observed.
The invention also provides application of the primer in preparation of a novel duck hepatitis C virus and duck picornavirus detection kit.
The invention also provides a kit for detecting duck hepatitis C virus and novel duck picornavirus, and the kit comprises the primer.
Compared with the prior art, the invention has the advantages that:
1. and (3) simultaneously detecting: the invention can establish a dual RT-PCR detection method for differential diagnosis of DuHCV and DuMV by using the primer, the method can simultaneously detect DuHCV and DuMV infection in duck groups, simplifies operation procedures, avoids repeated detection of conventional PCR, has the advantages of low cost, high efficiency and the like, and directly judges an amplification result by using different lengths of amplification fragments in the design of the primer, so that the method is simpler and more convenient in result judgment. If the detection sample only contains DuHCV, only one amplified target fragment is provided, and the size is 502 bp; if the detection sample only contains DuMV, only one amplified target fragment is provided, and the size of the amplified target fragment is 255 bp; if the detection sample contains DuHCV and DuMV, two amplified target fragments are provided, namely 502bp and 255bp respectively; if DuHCV and DuMV are not present in the test sample, no amplified band is observed.
2. The sensitivity is high: the duHCV minimum detection limit of the double RT-PCR detection method established by the invention is 3.79 multiplied by 101pg (i.e., 37.9pg), and the lowest detection limit of DuMV is 7.12X 101pg (i.e. 71.2 pg).
3. The specificity is strong: the dual RT-PCR detection method established by the primer has no reaction signals to common infectious diseases in duck groups such as DHAV-1, DHAV-3, AIV, APMV-1, MDRV and N-DRV, and only shows specific amplification bands to DuHCV and DuMV.
Drawings
FIG. 1 is an electrophoretogram showing the results of a specific test by the double RT-PCR method; wherein, M: DNA molecular weight DL 2000; 1: DuHCV; 2: DuMV; 3: DuHCV and DuMV co-infection; 4: DHAV-1; 5: DHAV-3; 6: an AIV; 7: APMV-1; 8: MDRV; 9: N-DRV.
FIG. 2 is an electrophoretogram of the results of the specificity test for DuHCV; wherein, M: DNA molecular weight DL 2000; 1: DuHCV; 2: DuMV; 3: DHAV-1; 4: DHAV-3; 5: an AIV; 6: APMV-1; 7: MDRV; 8: N-DRV.
FIG. 3 is an electrophoretogram of the results of the specificity test for DuMV; wherein, M: DNA molecular weight DL 2000; 1: DuMV; 2: DuHCV; 3: DHAV-1; 4: DHAV-3; 5: an AIV; 6: APMV-1; 7: MDRV; 8: N-DRV.
FIG. 4 is an electrophoretogram of the results of the double PCR duck hepatitis C virus susceptibility test; wherein, M: DNA molecular weight DL 2000; 1: 3.79X 105pg;2:3.79×104pg;3:3.79×103pg;4:3.79×102pg; 5:3.79×101pg;6:3.79×100pg; 7: negative controls were tested.
FIG. 5Is an electrophoretogram of the double PCR duck novel picornavirus sensitivity test result; wherein, M: DNA molecular weight DL 2000; 1: 7.12X 105pg;2:7.12×104pg;3:7.12×103pg;4:7.12×102pg; 5:7.12×101pg;6:7.12×100pg; 7: negative controls were tested.
Detailed Description
The invention is described in detail below with reference to the figures and examples of the specification. The experimental procedures used in the following examples are all conventional procedures unless otherwise specified. Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
Example 1
1. Materials and methods
1.1 strains and strains
Pathogenic duck hepatitis C virus (DuHCV, strain H36a 8), novel duck picornavirus (DuMV, strain M19g 24), duck hepatitis 1 virus (DHAV-1), duck hepatitis 3 virus (DHAV-3), duck Avian Influenza Virus (AIV), duck paramyxovirus 1 (APMV-1), Muscovy Duck Reovirus (MDRV) and novel duck reovirus (N-DRV) for the test are identified and stored by animal husbandry and veterinary research institute of agricultural academy of sciences of Fujian province.
1.2 design of primers
According to the genomic characteristics encoded by DuHCV and DuMV in the National Center of Biotechnology information, NCBI database GenBank, primer design software Oligo (v7.0) was used to target specific primers for DuHCV and DuMV, respectively, which were synthesized by Biotechnology engineering (Shanghai) GmbH.
Specific primers for DuHCV:
DuHCV-F:5’-GTTACTACCTATCTACGCAATT-3’;
DuHCV-R:5’-AGATGGCACTGGGATCGATGTA-3’;
the size of the target fragment is 502 bp.
Specific primers for DuMV:
DuMV-F:5’-TGTCAGCGCTATGATGGAGA-3’;
DuMV-R:5’-AATCCTTCCACCATCATCCAGT-3’;
the size of the target fragment was 255 bp.
1.3 extraction of nucleic acids and preparation of cDNA
Nucleic acid RNAs of DuHCV, DuMV, DHAV-1, DHAV-3, AIV, APMV-1, MDRV and N-DRV were extracted according to the Viral nucleic acid extraction Kit (Easypure Viral DNA/RNA Kit). Using a reverse transcription kit (
Figure BDA0002654373450000051
One-Step gDNA Removal and cDNA Synthesis SuperMix) reverse transcribing the extracted RNA into cDNA for use.
1.4 Dual RT-PCR method establishment
Amplification was performed according to the 50. mu.L system recommended by the Multiplex PCR Kit (Multiplex PCR Assay Kit Ver.2), wherein 25. mu.L of 2 × Multiplex PCR Buffer PCR amplification reaction solution, 0.4. mu.L of each of primers for DuHCV (DuHCV-F and DuHCV-R) (both primer concentrations are 10. mu. mol/L), 0.6. mu. L, PCR of each of amplimers for DuMV (DuMV-F and DuMV-R) (both primer concentrations are 10. mu. mol/L), 1.0. mu.L of each of prepared cDNA templates, and sterile deionized water were supplemented to a final volume of 50. mu.L, followed by PCR amplification after mixing. The optimized amplification conditions were: carrying out pre-denaturation at 94 ℃ for 120s, then carrying out circulation, carrying out denaturation at 94 ℃ for 30s, annealing at 57 ℃ for 45s, and extending at 72 ℃ for 45s, carrying out final extension at 72 ℃ for 10min after 35 cycles are finished, and carrying out identification according to conventional agarose gel electrophoresis after the reaction is finished.
The results are shown in FIG. 1: the size of the DuHCV target fragment is 502bp (lane 1); the size of the DuMV target fragment is 255bp (lane 2); the DuHCV and DuMV double positive amplified target fragments have two sizes, 502bp and 255bp respectively (lane 3).
1.5 specificity test
1.5.1 specificity test for Duck hepatitis C Virus
Utilizing specific primers (DuHCV-F and DuHCV-R) aiming at duck hepatitis C virus to perform PCR amplification on cDNA templates which are subjected to reverse transcription after RNA extraction of DuHCV, DuMV, DHAV-1, DHAV-3, AIV, APMV-1, MDRV and N-DRV; amplification was performed according to the 50. mu.L system recommended by the PCR kit (2 XEasyTaq PCR Supermix (+ dye)), wherein 25. mu.L of 2 XEasyTaq PCR Supermix Buffer PCR amplification reaction solution and 1.0. mu.L of 10. mu.M specific primers for duck hepatitis C virus (DuHCV-F and DuHCV-R) were added to 1. mu. L, cDNA template, respectively, and the final volume was 50. mu.L with sterile deionized water, and PCR amplification was performed after mixing. The amplification condition is pre-denaturation at 94 ℃ for 5min, then circulation is carried out, denaturation at 94 ℃ for 30s, annealing at 57 ℃ for 30s and extension at 72 ℃ for 40s, after 35 cycles are finished, final extension at 72 ℃ for 10min is carried out, and after the reaction is finished, the agarose gel electrophoresis identification is carried out according to the prior method. The results are shown in FIG. 2: the size of the DuHCV target fragment is 502 bp; no specific amplification bands were observed for DuMV, DHAV-1, DHAV-3, AIV, APMV-1, MDRV and N-DRV.
1.5.2 specificity test for novel duck picornaviruses
Utilizing specific primers (DuMV-F and DuMV-R) aiming at the novel duck picornaviruses to perform PCR amplification on cDNA templates which are subjected to reverse transcription after RNA extraction of DuHCV, DuMV, DHAV-1, DHAV-3, AIV, APMV-1, MDRV and N-DRV; amplification was performed according to a 50. mu.L system recommended by a PCR kit (2 XEasyTaq PCR Supermix (+ dye)), wherein 25. mu.L of the 2 XEasyTaq PCR Supermix Buffer PCR amplification reaction solution and 1.0. mu.L of 10. mu.M primers specific to the novel duck picornavirus (DuMV-F and DuMV-R) were added to a final volume of 50. mu.L each of 1. mu. L, cDNA template, and PCR amplification was performed after mixing. The amplification condition is pre-denaturation at 94 ℃ for 5min, then circulation is carried out, denaturation at 94 ℃ for 30s, annealing at 57 ℃ for 30s and extension at 72 ℃ for 40s, after 35 cycles are finished, final extension at 72 ℃ for 10min is carried out, and after the reaction is finished, the agarose gel electrophoresis identification is carried out according to the prior method. The results are shown in FIG. 3: the size of the target fragment of DuMV is 255 bp; no specific amplification bands were observed for DuHCV, DHAV-1, DHAV-3, AIV, APMV-1, MDRV and N-DRV.
1.5.3 specificity of the Dual RT-PCR method
According to the optimized multiplex PCR conditions of 1.4, the PCR amplification is carried out on the cDNA templates of DuHCV, DuMV, DHAV-1, DHAV-3, AIV, APMV-1, MDRV and N-DRV after RNA extraction and reverse transcription, the result is shown in figure 1, and the size of the DuHCV target fragment is 502bp (lane 1); the size of the DuMV target fragment is 255bp (lane 2); the DuHCV and DuMV double-positive amplified target fragments have two sizes, 502bp and 255bp respectively (lane 3), while DHAV-1 (lane 4), DHAV-3 (lane 5), AIV (lane 6), APMV-1 (lane 7), MDRV (lane 8) and N-DRV (lane 9) have no band amplification, which indicates that the method established by the invention has strong specificity.
1.6 sensitivity of the Dual RT-PCR method
DuHCV and DuMV extracted RNA were serially diluted 10-fold according to 1.4 optimized multiplex PCR conditions (DuHCV concentrations were 3.79X 10, respectively)5pg-3.79×100The pg and DuMV concentrations are 7.12X 105pg-7.12×100pg) are subjected to reverse transcription and then amplification is performed.
The results are shown in FIGS. 4 and 5: the lowest detection limit of DuHCV is 3.79X 101pg (i.e., 37.9pg) (FIG. 4, lane 5); the lowest detection limit of DuMV is 7.12 multiplied by 101pg (i.e., 71.2pg) (FIG. 5, lane 5).
1.7 clinical applications
According to the method, after 145 parts of clinical inspection duck-origin disease material is treated according to a conventional method, corresponding nucleic acid RNA is extracted by using a virus nucleic acid extraction Kit EasyPure Viral DNA/RNA Kit and then is reversely transcribed into cDNA, and the DuHCV and DuMV infection is detected by using an established duplex RT-PCR method. As a result, 21 DuHCV infections are detected to be positive, and the positive rate is 14.45%; 9 DuMV infection positives are detected, and the positive rate is 6.21%; 2 DuHCV and DuMV co-infection positives were detected with a positive rate of 1.38%.
And (3) cutting and recovering the positive target fragments after the double RT-PCR reaction is finished by using an agarose gel recovery kit. Cloning the amplified gene fragment onto pEASY-T1 vector according to pEASY-T1 Simple Cloning Kit instruction, randomly picking 8 single colonies, culturing in LB liquid culture medium with ampicillin resistance (content 100 ug/mL) for 14h, and extracting corresponding plasmid by using rapid plasmid miniextraction Kit. The extracted plasmid is subjected to PCR identification by adopting primers and conditions during double RT-PCR amplification, and the screened positive recombinant plasmid is sent to the company of Biotechnology engineering (Shanghai) Ltd for sequencing. The sequencing results are verified by BLAST analysis on NCBI, and are corresponding DuHCV and DuMV gene fragments, and the nucleotide homology of related gene sequences is respectively over 98.3 percent (DuHCV) and 98.8 percent (DuMV), which shows that the established method accords with the experimental expectation.
Sequence listing
<110> animal husbandry and veterinary institute of agricultural academy of sciences of Fujian province
<120> duck hepatitis C virus and novel duck picornavirus dual RT-PCR detection primers
<160>4
<170>SIPOSequenceListing 1.0
<210>1
<211>22
<212>DNA
<213> Artificial sequence (Artificial sequence)
<400>1
gttactacct atctacgcaa tt 22
<210>2
<211>22
<212>DNA
<213> Artificial sequence (Artificial sequence)
<400>2
agatggcact gggatcgatg ta 22
<210>3
<211>20
<212>DNA
<213> Artificial sequence (Artificial sequence)
<400>3
tgtcagcgct atgatggaga 20
<210>4
<211>22
<212>DNA
<213> Artificial sequence (Artificial sequence)
<400>4
aatccttcca ccatcatcca gt 22

Claims (4)

1. A dual RT-PCR detection primer for duck hepatitis C virus and novel duck picornavirus is characterized in that: the primers are as follows:
specific primers for duck hepatitis C virus:
DuHCV-F:5’-GTTACTACCTATCTACGCAATT-3’;
DuHCV-R:5’-AGATGGCACTGGGATCGATGTA-3’;
the size of the target fragment is 502 bp;
specific primers aiming at the novel duck picornavirus:
DuMV-F:5’-TGTCAGCGCTATGATGGAGA-3’;
DuMV-R:5’-AATCCTTCCACCATCATCCAGT-3’;
the size of the target fragment was 255 bp.
2. The dual RT-PCR detection method for detecting duck hepatitis C virus and novel duck picornavirus by using the primer of claim 1 is characterized in that: the PCR reaction system is as follows: the following components were contained in a 50. mu.L system:
component name Volume (μ L) 2 × Multiple PCR Buffer PCR amplification reaction solution 25 DuHCV-F(10μmol/L) 0.4 DuHCV-R(10μmol/L) 0.4 DuMV-F(10μmol/L) 0.6 DuMV-R(10μmol/L) 0.6 PCR amplification enzyme 0.25 cDNA template 1.0 Sterilizing deionized water 21.75
The PCR reaction conditions are as follows: carrying out pre-denaturation at 94 ℃ for 120s, then carrying out circulation, carrying out denaturation at 94 ℃ for 30s, annealing at 57 ℃ for 45s, and extending at 72 ℃ for 45s, and carrying out final extension at 72 ℃ for 10min after 35 cycles are finished.
3. The use of the primer of claim 1 in the preparation of a novel kit for detecting duck hepatitis C virus and duck picornavirus.
4. A kit for detecting duck hepatitis C virus and novel duck picornavirus is characterized in that: the kit comprises the primer of claim 1.
CN202010882032.4A 2020-08-28 2020-08-28 Duoble hepatitis C virus and duck novel micro ribonucleic acid virus dual RT-PCR detection primer Active CN111793723B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010882032.4A CN111793723B (en) 2020-08-28 2020-08-28 Duoble hepatitis C virus and duck novel micro ribonucleic acid virus dual RT-PCR detection primer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010882032.4A CN111793723B (en) 2020-08-28 2020-08-28 Duoble hepatitis C virus and duck novel micro ribonucleic acid virus dual RT-PCR detection primer

Publications (2)

Publication Number Publication Date
CN111793723A true CN111793723A (en) 2020-10-20
CN111793723B CN111793723B (en) 2022-05-20

Family

ID=72834038

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010882032.4A Active CN111793723B (en) 2020-08-28 2020-08-28 Duoble hepatitis C virus and duck novel micro ribonucleic acid virus dual RT-PCR detection primer

Country Status (1)

Country Link
CN (1) CN111793723B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112501355A (en) * 2020-12-15 2021-03-16 福建省农业科学院畜牧兽医研究所 Loop-mediated isothermal amplification detection primer group and kit for duck hepatitis C virus
CN118565951A (en) * 2024-07-31 2024-08-30 成都华西海圻医药科技有限公司 Epidermal micronucleus check drug composite solvent and epidermal cell micronucleus detection method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103088165A (en) * 2013-01-30 2013-05-08 山东农业大学 Multi-RT-PCR (Reverse Transcription-Polymerase Chain Reaction) method for rapidly identifying virus serotype of duck viral hepatitis
CN103509879A (en) * 2013-09-29 2014-01-15 山东省农业科学院家禽研究所 LAMP (Loop-Mediated Isothermal Amplification) detection kit commonly used for duck hepatitis A virus
CN105256074A (en) * 2015-11-17 2016-01-20 四川农业大学 Kit and method for detecting duck hepatitis A viruses through dual TaqMan fluorescent quantitation RT-PCR
CN107058634A (en) * 2017-06-13 2017-08-18 福建省农业科学院畜牧兽医研究所 The type of Ana 1 aviadenovirus 2 and Ana 1 aviadenovirus A type double PCR detection primers and kit
CN111500786A (en) * 2020-05-22 2020-08-07 福建省农业科学院畜牧兽医研究所 Universal detection kit for duck hepatitis A virus
CN111500784A (en) * 2020-05-22 2020-08-07 福建省农业科学院畜牧兽医研究所 Primer group for differential diagnosis of different types of duck hepatitis viruses

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103088165A (en) * 2013-01-30 2013-05-08 山东农业大学 Multi-RT-PCR (Reverse Transcription-Polymerase Chain Reaction) method for rapidly identifying virus serotype of duck viral hepatitis
CN103509879A (en) * 2013-09-29 2014-01-15 山东省农业科学院家禽研究所 LAMP (Loop-Mediated Isothermal Amplification) detection kit commonly used for duck hepatitis A virus
CN105256074A (en) * 2015-11-17 2016-01-20 四川农业大学 Kit and method for detecting duck hepatitis A viruses through dual TaqMan fluorescent quantitation RT-PCR
CN107058634A (en) * 2017-06-13 2017-08-18 福建省农业科学院畜牧兽医研究所 The type of Ana 1 aviadenovirus 2 and Ana 1 aviadenovirus A type double PCR detection primers and kit
CN111500786A (en) * 2020-05-22 2020-08-07 福建省农业科学院畜牧兽医研究所 Universal detection kit for duck hepatitis A virus
CN111500784A (en) * 2020-05-22 2020-08-07 福建省农业科学院畜牧兽医研究所 Primer group for differential diagnosis of different types of duck hepatitis viruses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LILI CHU等: "A highly divergent hepacivirus-like flavivirus in domestic ducks", 《JOURNAL OF GENERAL VIROLOGY》 *
QINFENG LIAO等: "Genomic characterization of a novel picornavirus in Pekin ducks", 《VETERINARY MICROBIOLOGY》 *
饶体宇等: "鸭瘟病毒、鹅细小病毒和番鸭细小病毒三重PCR检测方法的建立", 《畜牧与兽医》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112501355A (en) * 2020-12-15 2021-03-16 福建省农业科学院畜牧兽医研究所 Loop-mediated isothermal amplification detection primer group and kit for duck hepatitis C virus
CN118565951A (en) * 2024-07-31 2024-08-30 成都华西海圻医药科技有限公司 Epidermal micronucleus check drug composite solvent and epidermal cell micronucleus detection method
CN118565951B (en) * 2024-07-31 2024-10-25 成都华西海圻医药科技有限公司 Epidermis micro-check drug composite solvent and application thereof

Also Published As

Publication number Publication date
CN111793723B (en) 2022-05-20

Similar Documents

Publication Publication Date Title
CN107299155B (en) Primer and probe for real-time fluorescence quantitative PCR detection of goose astrovirus
CN110551853B (en) Triple PCR detection primer and kit for rapidly distinguishing African swine fever virus wild strain and gene deletion strain
CN107058634B (en) Duck adenovirus type 2 and duck adenovirus type A dual PCR detection primer and kit
CN107475458B (en) Goose astrovirus loop-mediated isothermal amplification detection primer group and kit
CN111793723B (en) Duoble hepatitis C virus and duck novel micro ribonucleic acid virus dual RT-PCR detection primer
CN113174446A (en) One-step double RT-PCR detection method for bovine viral diarrhea virus typing
CN106947834B (en) Multiplex PCR method for detecting six duck susceptibility viruses
CN111763775B (en) Primer group for real-time fluorescent quantitative PCR detection of DuHCV and DuMV dual TB Green
CN113584227B (en) Nested PCR (polymerase chain reaction) detection primer group and method for identifying African swine fever gene deletion strain
CN111763774B (en) Primer group and probe group for dual real-time fluorescent quantitative PCR detection of DuHCV and DuMV
KR102018079B1 (en) Primer set for detection of MERS-coronavirus and uses thereof
CN111893218B (en) Primer and probe for real-time fluorescent quantitative PCR detection of duck hepatitis C virus
CN114214466B (en) Novel goose astrovirus and duck tembusu virus multiplex fluorescence quantitative PCR detection primer probe set, kit and application
CN111763773A (en) Primer and probe for real-time fluorescent quantitative PCR detection of novel duck picornavirus
CN111500774B (en) Epidemic hemorrhagic disease virus and serotype identification RT-PCR kit
CN110564893B (en) Taqman probe fluorescent quantitative PCR kit and method for simultaneously detecting 3 viruses
CN112063750A (en) LAMP (Loop-mediated isothermal amplification) detection primer group of mandarin perch rhabdovirus, application of LAMP detection primer group and detection kit
CN111500786A (en) Universal detection kit for duck hepatitis A virus
CN111676319A (en) LAMP primer group and kit for detecting classical swine fever virus and using method thereof
CN108796132A (en) A kind of N-MDPV detection primers and probe and its application
CN111961758B (en) N-DMV and N-DHCLV dual real-time fluorescent quantitative PCR identification and detection primer and kit
CN110643739A (en) One-step triple RT-PCR detection primer and kit for distinguishing CHUV, BCV and DAV
CN112458213A (en) Novel loop-mediated isothermal amplification detection primer group and kit for duck picornaviruses
CN112266984B (en) Differential diagnosis method for discriminating DHAV-1 wild virus and vaccine attenuated virus
CN108823332A (en) The universal detection primer of one group of GPV and N-GPV and probe

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant